ES2187551T3 - Proteina l2 de papilomavirus modificada y vlps formadas a partir de la misma. - Google Patents
Proteina l2 de papilomavirus modificada y vlps formadas a partir de la misma.Info
- Publication number
- ES2187551T3 ES2187551T3 ES95907507T ES95907507T ES2187551T3 ES 2187551 T3 ES2187551 T3 ES 2187551T3 ES 95907507 T ES95907507 T ES 95907507T ES 95907507 T ES95907507 T ES 95907507T ES 2187551 T3 ES2187551 T3 ES 2187551T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- modified
- papilomavirus
- same
- vlps formed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
LA INVENCION, EN UN ASPECTO, ESTA DIRIGIDA A UNA PROTEINA L2 DE VIRUS DE PAPILOMA MODIFICADO LA CUAL NO UNE ADN O UNE UNA CANTIDAD SUBSTANCIALMENTE MINIMA DE ADN. LA INVENCION TAMBIEN ESTA DIRIGIDA A UN METODO DE PRODUCCION DE UNA O MAS PARTICULAS DEL TIPO-VIRUS QUE INCORPORAN UNA CANTIDAD MINIMA SUBSTANCIALMENTE DE ADN Y LAS PARTICULAS DEL TIPO-VIRUS PRODUCIDAS A PARTIR DE LAS MISMAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM3588A AUPM358894A0 (en) | 1994-01-31 | 1994-01-31 | Modified papilloma virus l2 protein and vlps formed therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2187551T3 true ES2187551T3 (es) | 2003-06-16 |
Family
ID=3778209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95907507T Expired - Lifetime ES2187551T3 (es) | 1994-01-31 | 1995-01-31 | Proteina l2 de papilomavirus modificada y vlps formadas a partir de la misma. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5993821A (es) |
EP (1) | EP0750669B1 (es) |
JP (1) | JP3417948B2 (es) |
KR (1) | KR100353762B1 (es) |
AT (1) | ATE226253T1 (es) |
AU (1) | AUPM358894A0 (es) |
DE (1) | DE69528578T2 (es) |
DK (1) | DK0750669T3 (es) |
ES (1) | ES2187551T3 (es) |
NZ (1) | NZ279166A (es) |
SG (1) | SG47362A1 (es) |
WO (1) | WO1995020659A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
GB9806666D0 (en) * | 1998-03-27 | 1998-05-27 | Stanley Margaret | Antigen preparation and use |
US7439016B1 (en) * | 2000-06-15 | 2008-10-21 | Digene Corporation | Detection of nucleic acids by type-specific hybrid capture method |
AUPR446801A0 (en) | 2001-04-18 | 2001-05-17 | University Of Queensland, The | Novel compositions and uses therefor |
JP2012506705A (ja) * | 2008-10-27 | 2012-03-22 | キアジェン ゲイサーズバーグ インコーポレイテッド | 迅速に結果を得るハイブリッドキャプチャー法による分析およびシステム |
CN107715118A (zh) * | 2009-08-26 | 2018-02-23 | 西莱克塔生物科技公司 | 诱导t细胞辅助的组合物 |
JP6153866B2 (ja) | 2010-05-25 | 2017-06-28 | キアゲン ガイサーズバーグ アイエヌシー. | 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ |
CN113075992B (zh) * | 2021-04-13 | 2022-07-05 | 浪潮电子信息产业股份有限公司 | 一种内存上电方法、装置、设备及计算机可读存储介质 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2641081A1 (es) * | 1988-12-23 | 1990-06-29 | Medgenix Group | |
GB9113809D0 (en) * | 1991-06-26 | 1991-08-14 | Cancer Res Campaign Tech | Papillomavirus l2 protein |
AU651727B2 (en) * | 1991-07-19 | 1994-07-28 | Csl Limited | Papilloma virus vaccine |
PT1618888E (pt) * | 1993-03-09 | 2011-04-08 | Univ Rochester | Produção de proteína da cápside de vírus de papiloma humano e partículas semelhantes a vírus |
GB9306731D0 (en) * | 1993-03-31 | 1993-05-26 | Cancer Res Campaign Tech | Vaccines |
-
1994
- 1994-01-31 AU AUPM3588A patent/AUPM358894A0/en not_active Abandoned
-
1995
- 1995-01-31 KR KR1019960704156A patent/KR100353762B1/ko active IP Right Grant
- 1995-01-31 SG SG1995001715A patent/SG47362A1/en unknown
- 1995-01-31 WO PCT/AU1995/000043 patent/WO1995020659A1/en active IP Right Grant
- 1995-01-31 JP JP51978995A patent/JP3417948B2/ja not_active Expired - Lifetime
- 1995-01-31 DE DE69528578T patent/DE69528578T2/de not_active Expired - Lifetime
- 1995-01-31 AT AT95907507T patent/ATE226253T1/de active
- 1995-01-31 DK DK95907507T patent/DK0750669T3/da active
- 1995-01-31 NZ NZ279166A patent/NZ279166A/en not_active IP Right Cessation
- 1995-01-31 ES ES95907507T patent/ES2187551T3/es not_active Expired - Lifetime
- 1995-01-31 EP EP95907507A patent/EP0750669B1/en not_active Expired - Lifetime
-
1996
- 1996-07-30 US US08/700,670 patent/US5993821A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR100353762B1 (ko) | 2002-12-26 |
SG47362A1 (en) | 1998-04-17 |
EP0750669B1 (en) | 2002-10-16 |
WO1995020659A1 (en) | 1995-08-03 |
JP3417948B2 (ja) | 2003-06-16 |
US5993821A (en) | 1999-11-30 |
AUPM358894A0 (en) | 1994-02-24 |
NZ279166A (en) | 1997-11-24 |
JPH09508273A (ja) | 1997-08-26 |
DE69528578T2 (de) | 2003-07-17 |
DK0750669T3 (da) | 2003-02-24 |
EP0750669A1 (en) | 1997-01-02 |
EP0750669A4 (en) | 1998-05-27 |
DE69528578D1 (de) | 2002-11-21 |
ATE226253T1 (de) | 2002-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0862633T3 (da) | VP-antigen af JC-virus | |
DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
ES2135062T3 (es) | Pirazolo y pirrolopiridinas. | |
ATE508635T1 (de) | Virusvektoren und ihre verwendung bei therapeutischen methoden | |
ATE411082T1 (de) | Neue verwendung von kurzkettigen carbonsäuren | |
ES2333598T5 (es) | Proteinas quimericas del factor de coagulacion fc para tratar la hemofilia. | |
FI964592A0 (fi) | Papilloomavirusrokotteita | |
ATE317441T1 (de) | Cathepsin-02-protease | |
DE50012863D1 (de) | Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften | |
GB0100513D0 (en) | Process | |
DE69939312D1 (de) | Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen | |
ES2187551T3 (es) | Proteina l2 de papilomavirus modificada y vlps formadas a partir de la misma. | |
CY1105380T1 (el) | Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων | |
DE50111331D1 (de) | Neue verwendung von proteinhydrolysaten | |
ATE309356T1 (de) | Konstruierte fluoreszenzproteine mit langen wellenlängen | |
EA200200974A1 (ru) | Моноклональные антитела к рецептору лпнп человека, их получение и применение | |
IL156799A0 (en) | Peptides having affinity for the gp120 viral protein and use thereof | |
ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
WO2004043996A3 (en) | Ligands | |
EA200400751A1 (ru) | Применение дезоксипеганина для лечения клинической депрессии | |
ATE309371T1 (de) | Protein mit dnase-aktivität | |
EA200400393A1 (ru) | Антитела против каспазы-8, их получение и применение | |
HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
ATE283358T1 (de) | Protease-ähnliches protein | |
DE50210279D1 (de) | Screeningverfahren mit bnpi und dnpi |